---
url: https://www.prnewswire.com/news-releases/labcorp-launches-labcorp-whole-health-solutions-to-support-holistic-care-302484695.html
title: "Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care"
clipped: 2025-12-23 13:06
source: slack
slack_channel: mkt-research-headlines
---

# Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care

> Source: [https://www.prnewswire.com/news-releases/labcorp-launches-labcorp-whole-health-solutions-to-support-holistic-care-302484695.html](https://www.prnewswire.com/news-releases/labcorp-launches-labcorp-whole-health-solutions-to-support-holistic-care-302484695.html)

*New offering delivers convenient, comprehensive lab testing solutions for functional medicine, integrative medicine and primary care providers*

BURLINGTON, N.C., June 18, 2025 /PRNewswire/ -- Labcorp (NYSE: [LH](#financial-modal)), a global leader of innovative and comprehensive laboratory services, announced today the launch of [Labcorp Whole Health Solutions](https://c212.net/c/link/?t=0&l=en&o=4451797-1&h=670611564&u=https%3A%2F%2Fwww.labcorp.com%2Fproviders%2Fwhole-health-solutions&a=Labcorp+Whole+Health+Solutions) to support the growing needs of functional medicine, integrative medicine and primary care providers in delivering holistic care. The solution launches specialized test panels and a tailored test menu of more than 1,000 scientifically backed biomarkers for cardiometabolic health, hormones, micronutrients, longevity and whole body wellness.

[Continue Reading](#continue-jump)

[![Photo courtesy of Labcorp]( "Photo courtesy of Labcorp")](#)

Photo courtesy of Labcorp

Patients and healthcare providers are increasingly embracing integrative and functional medicine approaches, seeking comprehensive and holistic strategies that are tailored to an individual's unique needs. Approximately [37%](https://c212.net/c/link/?t=0&l=en&o=4451797-1&h=2259373455&u=https%3A%2F%2Fwww.nccih.nih.gov%2Fnews%2Fpress-releases%2Fnih-analysis-reveals-a-significant-rise-in-use-of-complementary-health-approaches-especially-for-pain-management&a=37%25) of U.S. adults, or about 122 million people, used at least one complementary or integrative health approach in 2022, according to the National Institutes of Health's (NIH) National Center for Complementary and Integrative Health (NCCIH). Labcorp has also seen steady growth in the number of integrative and functional practitioners it serves.

"At Labcorp, we recognize the growing demand for more comprehensive healthcare solutions, and our new offering is a direct response to this evolving landscape," said Dr. Brian Caveney, Labcorp's chief medical and scientific officer. "By expanding access to our scientifically validated biomarkers and test panels, we're empowering healthcare providers with convenient tests that provide a more robust view of their patients' health to deliver comprehensive and holistic care."

**Key Features of Labcorp Whole Health Solutions**Built from the company's expansive menu of more than 6,500 tests, Labcorp Whole Health Solutions offers healthcare providers a tailored test menu of more than 1,000 biomarkers and seven test panels to provide cardiometabolic health, hormones, micronutrients, longevity and whole body wellness insights. The initial panels include:

* **Advanced Cardiometabolic Biomarker Panel**
* **Comprehensive Nutrient Panel**
* **Longevity and Vitality Panel**
* **Men's Comprehensive Hormone Panel**
* **Men's Whole Body Wellness Panel**
* **Women's Comprehensive Hormone Panel**
* **Women's Whole Body Wellness Panel**

Patient specimen collections are available through a physician office or at any one of Labcorp's more than 2,200 patient service centers (PSCs) nationwide.

For more information, visit [https://www.labcorp.com/providers/whole-health-solutions](https://c212.net/c/link/?t=0&l=en&o=4451797-1&h=3707495933&u=https%3A%2F%2Fwww.labcorp.com%2Fproviders%2Fwhole-health-solutions&a=https%3A%2F%2Fwww.labcorp.com%2Fproviders%2Fwhole-health-solutions)

**About Labcorp**Labcorp (NYSE: [LH](#financial-modal)) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at [www.labcorp.com](https://c212.net/c/link/?t=0&l=en&o=4451797-1&h=4135743315&u=http%3A%2F%2Fwww.labcorp.com%2F&a=www.labcorp.com).

SOURCE Labcorp

![](https://rt.prnewswire.com/rt.gif?NewsItemId=DC13120&Transmission_Id=202506180700PR_NEWS_USPR_____DC13120&DateId=20250618)

[![](/content/dam/newWidget-desktop.png)

## 21%

more press release views with ![](/content/dam/amplify-logo.png)

Request a Demo](https://www.prnewswire.com/amplify-platform/?site_refer=press-release-widget)

×

### Modal title

## Also from this source

[![Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research](https://mma.prnewswire.com/media/2044800/Labcorp_Logo.jpg?w=300)](labcorp-plasma-detect-clinical-studies-featured-in-nature-medicine-and-clinical-cancer-research-302620138.html)

[### Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced Labcorp Plasma Detect, a tumor-informed,...](labcorp-plasma-detect-clinical-studies-featured-in-nature-medicine-and-clinical-cancer-research-302620138.html)

[![Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings](https://mma.prnewswire.com/media/2044800/Labcorp_Logo.jpg?w=300)](labcorp-to-offer-first-fda-cleared-blood-test-to-rule-out-alzheimers-related-amyloid-pathology-in-primary-care-settings-302592423.html)

[### Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the...](labcorp-to-offer-first-fda-cleared-blood-test-to-rule-out-alzheimers-related-amyloid-pathology-in-primary-care-settings-302592423.html)

[More Releases From This Source](/news/labcorp/)

## Explore

[![Health Care & Hospitals](/content/dam/prnewswire/subject-and-industry-code-images/HEA.jpg)](/news-releases/health-latest-news/health-care-hospitals-list/)

[Health Care & Hospitals](/news-releases/health-latest-news/health-care-hospitals-list/)

[![Medical Pharmaceuticals](/content/dam/prnewswire/subject-and-industry-code-images/MTC.jpg)](/news-releases/health-latest-news/medical-pharmaceuticals-list/)

[Medical Pharmaceuticals](/news-releases/health-latest-news/medical-pharmaceuticals-list/)

[![New Products & Services](/content/dam/prnewswire/subject-and-industry-code-images/PDT.jpg)](/news-releases/general-business-latest-news/new-products-services-list/)

[New Products & Services](/news-releases/general-business-latest-news/new-products-services-list/)

[News Releases in Similar Topics](/news-releases/)